CD8A and breast carcinoma: CD8 + cytotoxic T lymphocytes are crucial predictors of response to anthracycline-based chemotherapy in breast cancer, underscoring the role of the immune system in treatment efficacy (Darwin et al. 2020; Deswangga and Alsoph 2018).